Literature DB >> 30103835

Is vaccinating monkeys against yellow fever the ultimate solution for the Brazilian recurrent epizootics?

Eduardo Massad1, Mônica Manir Miguel1, Francisco Antonio Bezerra Coutinho1.   

Abstract

Vaccinating monkeys against yellow fever (YF) has been a common practice in the beginning of the 17D vaccine development. Although it may seem strange at first sight, vaccinating monkeys as a public health strategy is, we think, feasible and theoretically could eliminate the infection among non-human primates, interrupting the virus circulation (or significantly reducing it) and therefore reducing the risk of spilling over to the human population. We propose a series of studies that could demonstrate (or not) the efficacy and feasibility of vaccinating non-human primates YF reservoirs living in green areas of urban centres to cut off or curb the virus circulation that recurrently spill over to the human population. Therefore, vaccinating monkeys in relatively small green areas of the urban centres is perhaps the ultimate solution for the Brazilian recurrent YF epizootics.

Entities:  

Keywords:  dengue fever; Mathematical modelling; medical informatics (veterinary and medical)

Mesh:

Substances:

Year:  2018        PMID: 30103835      PMCID: PMC9507961          DOI: 10.1017/S0950268818002273

Source DB:  PubMed          Journal:  Epidemiol Infect        ISSN: 0950-2688            Impact factor:   4.434


  7 in total

1.  Yellow fever epizootics in non-human primates, São Paulo state, Brazil, 2008-2009.

Authors:  Eduardo Stramandinoli Moreno; Roberta Spinola; Cilea Hatsumi Tengan; Roosecelis Araujo Brasil; Melissa Mascheratti Siciliano; Terezinha Lisieux Moraes Coimbra; Vivian Regina Silveira; Iray Maria Rocco; Ivani Bisordi; Renato Pereira de Souza; Selma Petrella; Luiz Eloy Pereira; Adriana Yurika Maeda; Fernanda Giselle da Silva; Akemi Suzuki
Journal:  Rev Inst Med Trop Sao Paulo       Date:  2013 Jan-Feb       Impact factor: 1.846

2.  Protection against yellow fever in monkeys by immunization with yellow fever virus nonstructural protein NS1.

Authors:  J J Schlesinger; M W Brandriss; C B Cropp; T P Monath
Journal:  J Virol       Date:  1986-12       Impact factor: 5.103

3.  Yellow fever vaccine: direct challenge of monkeys given graded doses of 17D vaccine.

Authors:  R A Mason; N M Tauraso; R O Spertzel; R K Ginn
Journal:  Appl Microbiol       Date:  1973-04

4.  The risk of yellow fever in a dengue-infested area.

Authors:  E Massad; F A Coutinho; M N Burattini; L F Lopez
Journal:  Trans R Soc Trop Med Hyg       Date:  2001 Jul-Aug       Impact factor: 2.184

5.  Habitat, density and group size of primates in a Brazilian tropical forest.

Authors:  L P Pinto; C M Costa; K B Strier; G A da Fonseca
Journal:  Folia Primatol (Basel)       Date:  1993       Impact factor: 1.246

6.  The risk of urban yellow fever resurgence in Aedes-infested American cities.

Authors:  Eduardo Massad; Marcos Amaku; Francisco Antonio Bezerra Coutinho; Claudio José Struchiner; Luis Fernandez Lopez; Giovanini Coelho; Annelies Wilder-Smith; Marcelo Nascimento Burattini
Journal:  Epidemiol Infect       Date:  2018-05-30       Impact factor: 4.434

7.  Estimating the size of Aedes aegypti populations from dengue incidence data: Implications for the risk of yellow fever outbreaks.

Authors:  Eduardo Massad; Marcos Amaku; Francisco Antonio Bezerra Coutinho; Claudio José Struchiner; Luis Fernandez Lopez; Annelies Wilder-Smith; Marcelo Nascimento Burattini
Journal:  Infect Dis Model       Date:  2017-12-08
  7 in total
  3 in total

Review 1.  Yellow fever control: current epidemiology and vaccination strategies.

Authors:  Lin H Chen; Mary E Wilson
Journal:  Trop Dis Travel Med Vaccines       Date:  2020-01-10

2.  Re-emergence of yellow fever in the neotropics - quo vadis?

Authors:  Livia Sacchetto; Betania P Drumond; Barbara A Han; Mauricio L Nogueira; Nikos Vasilakis
Journal:  Emerg Top Life Sci       Date:  2020-12-11

Review 3.  Yellow Fever: Origin, Epidemiology, Preventive Strategies and Future Prospects.

Authors:  Elena Gianchecchi; Virginia Cianchi; Alessandro Torelli; Emanuele Montomoli
Journal:  Vaccines (Basel)       Date:  2022-02-27
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.